Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | phosphatidylinositol kinase related protein, putative | 0.0022 | 0.0615 | 0.0576 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0046 | 0.2411 | 0.2843 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0016 | 0.0159 | 0.5 |
Brugia malayi | Thioredoxin reductase | 0.0046 | 0.2411 | 0.2843 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0022 | 0.0612 | 0.0572 |
Leishmania major | trypanothione reductase | 0.0046 | 0.2411 | 0.2843 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0022 | 0.0612 | 0.0572 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0022 | 0.0612 | 0.0572 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0022 | 0.0612 | 0.0572 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0121 | 0.8078 | 0.8047 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0105 | 0.6825 | 0.8837 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0016 | 0.0159 | 0.5 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0121 | 0.8078 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0046 | 0.2411 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0022 | 0.0612 | 0.0572 |
Entamoeba histolytica | hypothetical protein | 0.003 | 0.1228 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0105 | 0.6825 | 0.8837 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0.0159 | 0.5 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0105 | 0.6825 | 0.8837 |
Brugia malayi | glutathione reductase | 0.0046 | 0.2411 | 0.2843 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0121 | 0.8078 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0016 | 0.0159 | 0.0197 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0022 | 0.0612 | 0.0572 |
Echinococcus granulosus | serine protein kinase ATM | 0.003 | 0.1228 | 0.1349 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0121 | 0.8078 | 1 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0022 | 0.0612 | 0.0758 |
Trypanosoma brucei | trypanothione reductase | 0.0046 | 0.2411 | 0.2984 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.003 | 0.1228 | 0.1349 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0026 | 0.0911 | 0.0949 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0121 | 0.8078 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0046 | 0.2411 | 1 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0022 | 0.0612 | 0.0758 |
Treponema pallidum | NADH oxidase | 0.0016 | 0.0159 | 0.5 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0116 | 0.7702 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0047 | 0.2457 | 0.2902 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0022 | 0.0612 | 0.0758 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0046 | 0.2411 | 1 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0121 | 0.8078 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0022 | 0.0612 | 0.0758 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0022 | 0.0612 | 0.0758 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0121 | 0.8078 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0121 | 0.8078 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.003 | 0.1228 | 0.1349 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0022 | 0.0612 | 0.0758 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.003 | 0.1228 | 0.152 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0116 | 0.7702 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0022 | 0.0612 | 0.0572 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0016 | 0.0159 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0105 | 0.6825 | 0.8837 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0022 | 0.0615 | 0.0576 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0.0159 | 0.5 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0046 | 0.2411 | 0.2984 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.003 | 0.1228 | 0.152 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0121 | 0.8078 | 1 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0016 | 0.0159 | 0.0197 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0016 | 0.0159 | 0.5 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0022 | 0.0612 | 0.0572 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0022 | 0.0612 | 0.0572 |
Plasmodium falciparum | glutathione reductase | 0.0046 | 0.2411 | 1 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0121 | 0.8078 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0121 | 0.8078 | 1 |
Toxoplasma gondii | FATC domain-containing protein | 0.003 | 0.1228 | 0.152 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0121 | 0.8078 | 1 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0016 | 0.0159 | 0.0197 |
Leishmania major | phosphatidylinositol 3-related kinase, putative | 0.0022 | 0.0612 | 0.0572 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0016 | 0.0159 | 0.0197 |
Trypanosoma brucei | protein kinase, putative | 0.0121 | 0.8078 | 1 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0022 | 0.0612 | 0.0572 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0016 | 0.0159 | 0.0197 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0022 | 0.0612 | 0.0572 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0121 | 0.8078 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0022 | 0.0612 | 0.0758 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0116 | 0.7702 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0022 | 0.0612 | 0.0572 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0121 | 0.8078 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0116 | 0.7702 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0105 | 0.6825 | 0.8837 |
Loa Loa (eye worm) | glutathione reductase | 0.0046 | 0.2411 | 0.2984 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0121 | 0.8078 | 1 |
Giardia lamblia | GTOR | 0.0022 | 0.0612 | 0.0572 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0911 | 0.1127 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0121 | 0.8078 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0121 | 0.8078 | 1 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0016 | 0.0159 | 0.0197 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.003 | 0.1228 | 0.1086 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0022 | 0.0612 | 0.0461 |
Leishmania major | phosphatidylinositol 3-kinase, putative | 0.0022 | 0.0612 | 0.0572 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0047 | 0.2457 | 0.2902 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0022 | 0.0612 | 0.0572 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0022 | 0.0612 | 0.0572 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0121 | 0.8078 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0022 | 0.0612 | 0.0758 |
Mycobacterium tuberculosis | Probable reductase | 0.0105 | 0.6825 | 0.8837 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Toxoplasma gondii | thioredoxin reductase | 0.0046 | 0.2411 | 0.2984 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0016 | 0.0159 | 0.0197 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0016 | 0.0159 | 0.0197 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0046 | 0.2411 | 0.2985 |
Echinococcus multilocularis | serine protein kinase ATM | 0.003 | 0.1228 | 0.1349 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0022 | 0.0612 | 0.0758 |
Brugia malayi | MAP kinase sur-1 | 0.0121 | 0.8078 | 1 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0022 | 0.0612 | 0.0461 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0121 | 0.8078 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 55 uM | Antiplasmodial activity against chloroquine-sussceptible Plasmodium falciparum FCR3 | ChEMBL. | 18220356 |
IC50 (functional) | = 55 uM | Antiplasmodial activity against chloroquine-sussceptible Plasmodium falciparum FCR3 | ChEMBL. | 18220356 |
IC50 (functional) | = 137 uM | Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 | ChEMBL. | 18220356 |
IC50 (functional) | = 137 uM | Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 | ChEMBL. | 18220356 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.